Free Trial

Treatt (TET) Competitors

Treatt logo
GBX 270.62 +13.62 (+5.30%)
As of 07:04 AM Eastern

TET vs. SCPA, ESNT, SYNT, ZTF, IOF, WCH, ITX, DCTA, HDD, and BIOM

Should you be buying Treatt stock or one of its competitors? The main competitors of Treatt include Scapa Group (SCPA), Essentra (ESNT), Synthomer (SYNT), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Hardide (HDD), and Biome Technologies (BIOM). These companies are all part of the "specialty chemicals" industry.

Treatt vs.

Treatt (LON:TET) and Scapa Group (LON:SCPA) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Treatt has higher earnings, but lower revenue than Scapa Group. Scapa Group is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treatt£142.31M1.14£11.22M£18.5114.51
Scapa Group£281.80M0.00N/A-£29.30N/A

50.9% of Treatt shares are owned by institutional investors. 13.4% of Treatt shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Treatt has a net margin of 7.88% compared to Scapa Group's net margin of 0.00%. Treatt's return on equity of 8.09% beat Scapa Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Treatt7.88% 8.09% 6.72%
Scapa Group N/A N/A N/A

In the previous week, Treatt had 2 more articles in the media than Scapa Group. MarketBeat recorded 2 mentions for Treatt and 0 mentions for Scapa Group. Treatt's average media sentiment score of 0.48 beat Scapa Group's score of 0.00 indicating that Treatt is being referred to more favorably in the media.

Company Overall Sentiment
Treatt Neutral
Scapa Group Neutral

Scapa Group received 33 more outperform votes than Treatt when rated by MarketBeat users. However, 68.97% of users gave Treatt an outperform vote while only 56.27% of users gave Scapa Group an outperform vote.

CompanyUnderperformOutperform
TreattOutperform Votes
160
68.97%
Underperform Votes
72
31.03%
Scapa GroupOutperform Votes
193
56.27%
Underperform Votes
150
43.73%

Treatt currently has a consensus price target of GBX 650, suggesting a potential upside of 142.09%. Given Treatt's stronger consensus rating and higher probable upside, analysts clearly believe Treatt is more favorable than Scapa Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treatt
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Scapa Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Treatt beats Scapa Group on 13 of the 15 factors compared between the two stocks.

Get Treatt News Delivered to You Automatically

Sign up to receive the latest news and ratings for TET and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TET vs. The Competition

MetricTreattSpecialty Chemicals IndustryMaterials SectorLON Exchange
Market Cap£162.34M£8.26B£3.10B£2.68B
Dividend Yield2.00%3.58%5.08%4.96%
P/E Ratio14.5113.2670.93134.16
Price / Sales1.1449.8826,914,679,906,498,300.00210,682.22
Price / Cash165.4319.2524.3628.03
Price / Book1.154.725.213.80
Net Income£11.22M£220.83M£154.55M£5.88B
7 Day Performance4.47%1.71%1.63%7.88%
1 Month Performance18.54%7.22%4.72%29.38%
1 Year Performance-45.87%-18.65%15.25%119.43%

Treatt Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TET
Treatt
2.9143 of 5 stars
GBX 270.62
+5.3%
GBX 650
+140.2%
-47.6%£163.62M£142.31M14.62350News Coverage
Positive News
Dividend Increase
Gap Up
High Trading Volume
SCPA
Scapa Group
N/AN/AN/AN/A£402.98M£281.80M-7.321,461
ESNT
Essentra
1.7206 of 5 stars
GBX 99.10
+0.4%
GBX 206.67
+108.5%
-45.7%£284.85M£309.74M81.64350News Coverage
SYNT
Synthomer
2.1528 of 5 stars
GBX 112.55
+1.4%
GBX 225
+99.9%
-69.4%£184.56M£1.87B-2.264,200Gap Down
ZTF
Zotefoams
N/AGBX 271
+6.7%
N/A-47.9%£130.35M£131.66M13.12549
IOF
Iofina
2.0872 of 5 stars
GBX 23.17
-1.4%
GBX 36.25
+56.5%
+10.8%£55.62M£61.34M16.2695
WCH
Wilmcote Holdings plc (WCH.L)
N/AN/AN/AN/A£20.13MN/A-5.003
ITX
Itaconix
N/AGBX 110
+4.8%
N/A-37.7%£14.84M£5.28M-9.9617Gap Down
DCTA
Directa Plus
N/AGBX 7.25
+4.3%
N/A-67.8%£9.75M£20.29M-1.29187
HDD
Hardide
N/AGBX 6.77
-1.5%
N/A+15.2%£5.34M£6.11M-2.8346Earnings Report
BIOM
Biome Technologies
N/AGBX 10
-0.5%
N/A-83.6%£5.16M£78.36M-0.2927

Related Companies and Tools


This page (LON:TET) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners